PSILOCYBIN AND KETANSERIN VS RTMS IN TREATMENT-RESISTANT DEPRESSION: ENHANCING TOLERABILITY BY MITIGATING PSYCHEDELIC EFFECTS

Authors
Category Primary study
Conference36th CINP World Congress Neuropsychopharmacology -CINP-AsCNP 2025 Congress
Year 2025
This article has no abstract
Epistemonikos ID: 06f486cedff2e787363e02ec7298c9c15b08dcfe
First added on: Nov 28, 2025